A NEW METHOD FOR ESTIMATING SERUM ACID PHOSPHATASE OF PROSTATIC ORIGIN APPLIED TO THE CLINICAL INVESTIGATION OF CANCER OF THE PROSTATE

^{Cancer Research and Cancer Control Unit and the Department of Surgery, Tufts College Medical School, Boston, Massachusetts}

^{Cancer Research and Cancer Control Unit and the Department of Medicine, Tufts College Medical School, Boston, Massachusetts}

^{Cancer Research and Cancer Control Unit and the Department of Biochemistry, Tufts College Medical School, Boston, Massachusetts}

^{Cancer Research and Cancer Control Unit and the Department of Nutrition, Tufts College Medical School, Boston, Massachusetts}

^{Biochemistry Laboratory of the Holy Ghost Hospital, Cambridge, Mass.}

This investigation was supported in part by a grant-in-aid of the American Cancer Society, Massachusetts Division, the U. S. Public Health Service, National Cancer Institute (Cancer Control Division), Bethesda, Maryland, and by funds from an Institutional Grant of the American Cancer Society, Inc., New York, N. Y. The helpful cooperation of Drs. J.Hartwell Harrison (Peter Bent Brigham Hospital), L. Gottlieb, L. F. H. Taylor (Boston City Hospital), and A. d'Agostino, is gratefully acknowledged. The testosterone used in this study was kindly provided by the Organon Company, Nutley, New Jersey, and by the Schering Corporation, Bloomfield, New Jersey.

Presented before the Forty-Fourth Annual Meeting of the American Association for Cancer Research (1), April 9, 1953.

Find articles by Fishman, W. in: JCI | PubMed | Google Scholar

^{Cancer Research and Cancer Control Unit and the Department of Surgery, Tufts College Medical School, Boston, Massachusetts}

^{Cancer Research and Cancer Control Unit and the Department of Medicine, Tufts College Medical School, Boston, Massachusetts}

^{Cancer Research and Cancer Control Unit and the Department of Biochemistry, Tufts College Medical School, Boston, Massachusetts}

^{Cancer Research and Cancer Control Unit and the Department of Nutrition, Tufts College Medical School, Boston, Massachusetts}

^{Biochemistry Laboratory of the Holy Ghost Hospital, Cambridge, Mass.}

This investigation was supported in part by a grant-in-aid of the American Cancer Society, Massachusetts Division, the U. S. Public Health Service, National Cancer Institute (Cancer Control Division), Bethesda, Maryland, and by funds from an Institutional Grant of the American Cancer Society, Inc., New York, N. Y. The helpful cooperation of Drs. J.Hartwell Harrison (Peter Bent Brigham Hospital), L. Gottlieb, L. F. H. Taylor (Boston City Hospital), and A. d'Agostino, is gratefully acknowledged. The testosterone used in this study was kindly provided by the Organon Company, Nutley, New Jersey, and by the Schering Corporation, Bloomfield, New Jersey.

Presented before the Forty-Fourth Annual Meeting of the American Association for Cancer Research (1), April 9, 1953.

Find articles by Dart, R. in: JCI | PubMed | Google Scholar

^{Cancer Research and Cancer Control Unit and the Department of Surgery, Tufts College Medical School, Boston, Massachusetts}

^{Cancer Research and Cancer Control Unit and the Department of Medicine, Tufts College Medical School, Boston, Massachusetts}

^{Cancer Research and Cancer Control Unit and the Department of Biochemistry, Tufts College Medical School, Boston, Massachusetts}

^{Cancer Research and Cancer Control Unit and the Department of Nutrition, Tufts College Medical School, Boston, Massachusetts}

^{Biochemistry Laboratory of the Holy Ghost Hospital, Cambridge, Mass.}

This investigation was supported in part by a grant-in-aid of the American Cancer Society, Massachusetts Division, the U. S. Public Health Service, National Cancer Institute (Cancer Control Division), Bethesda, Maryland, and by funds from an Institutional Grant of the American Cancer Society, Inc., New York, N. Y. The helpful cooperation of Drs. J.Hartwell Harrison (Peter Bent Brigham Hospital), L. Gottlieb, L. F. H. Taylor (Boston City Hospital), and A. d'Agostino, is gratefully acknowledged. The testosterone used in this study was kindly provided by the Organon Company, Nutley, New Jersey, and by the Schering Corporation, Bloomfield, New Jersey.

Presented before the Forty-Fourth Annual Meeting of the American Association for Cancer Research (1), April 9, 1953.

Find articles by Bonner, C. in: JCI | PubMed | Google Scholar

^{Cancer Research and Cancer Control Unit and the Department of Surgery, Tufts College Medical School, Boston, Massachusetts}

^{Cancer Research and Cancer Control Unit and the Department of Medicine, Tufts College Medical School, Boston, Massachusetts}

^{Cancer Research and Cancer Control Unit and the Department of Biochemistry, Tufts College Medical School, Boston, Massachusetts}

^{Cancer Research and Cancer Control Unit and the Department of Nutrition, Tufts College Medical School, Boston, Massachusetts}

^{Biochemistry Laboratory of the Holy Ghost Hospital, Cambridge, Mass.}

This investigation was supported in part by a grant-in-aid of the American Cancer Society, Massachusetts Division, the U. S. Public Health Service, National Cancer Institute (Cancer Control Division), Bethesda, Maryland, and by funds from an Institutional Grant of the American Cancer Society, Inc., New York, N. Y. The helpful cooperation of Drs. J.Hartwell Harrison (Peter Bent Brigham Hospital), L. Gottlieb, L. F. H. Taylor (Boston City Hospital), and A. d'Agostino, is gratefully acknowledged. The testosterone used in this study was kindly provided by the Organon Company, Nutley, New Jersey, and by the Schering Corporation, Bloomfield, New Jersey.

Presented before the Forty-Fourth Annual Meeting of the American Association for Cancer Research (1), April 9, 1953.

Find articles by Leadbetter, W. in: JCI | PubMed | Google Scholar

^{Cancer Research and Cancer Control Unit and the Department of Surgery, Tufts College Medical School, Boston, Massachusetts}

^{Cancer Research and Cancer Control Unit and the Department of Medicine, Tufts College Medical School, Boston, Massachusetts}

^{Cancer Research and Cancer Control Unit and the Department of Biochemistry, Tufts College Medical School, Boston, Massachusetts}

^{Cancer Research and Cancer Control Unit and the Department of Nutrition, Tufts College Medical School, Boston, Massachusetts}

^{Biochemistry Laboratory of the Holy Ghost Hospital, Cambridge, Mass.}

This investigation was supported in part by a grant-in-aid of the American Cancer Society, Massachusetts Division, the U. S. Public Health Service, National Cancer Institute (Cancer Control Division), Bethesda, Maryland, and by funds from an Institutional Grant of the American Cancer Society, Inc., New York, N. Y. The helpful cooperation of Drs. J.Hartwell Harrison (Peter Bent Brigham Hospital), L. Gottlieb, L. F. H. Taylor (Boston City Hospital), and A. d'Agostino, is gratefully acknowledged. The testosterone used in this study was kindly provided by the Organon Company, Nutley, New Jersey, and by the Schering Corporation, Bloomfield, New Jersey.

Presented before the Forty-Fourth Annual Meeting of the American Association for Cancer Research (1), April 9, 1953.

Find articles by Lerner, F. in: JCI | PubMed | Google Scholar

^{Cancer Research and Cancer Control Unit and the Department of Surgery, Tufts College Medical School, Boston, Massachusetts}

^{Cancer Research and Cancer Control Unit and the Department of Medicine, Tufts College Medical School, Boston, Massachusetts}

^{Cancer Research and Cancer Control Unit and the Department of Biochemistry, Tufts College Medical School, Boston, Massachusetts}

^{Cancer Research and Cancer Control Unit and the Department of Nutrition, Tufts College Medical School, Boston, Massachusetts}

^{Biochemistry Laboratory of the Holy Ghost Hospital, Cambridge, Mass.}

This investigation was supported in part by a grant-in-aid of the American Cancer Society, Massachusetts Division, the U. S. Public Health Service, National Cancer Institute (Cancer Control Division), Bethesda, Maryland, and by funds from an Institutional Grant of the American Cancer Society, Inc., New York, N. Y. The helpful cooperation of Drs. J.Hartwell Harrison (Peter Bent Brigham Hospital), L. Gottlieb, L. F. H. Taylor (Boston City Hospital), and A. d'Agostino, is gratefully acknowledged. The testosterone used in this study was kindly provided by the Organon Company, Nutley, New Jersey, and by the Schering Corporation, Bloomfield, New Jersey.

Presented before the Forty-Fourth Annual Meeting of the American Association for Cancer Research (1), April 9, 1953.

Find articles by Homburger, F. in: JCI | PubMed | Google Scholar